C. Valenzuela (Madrid, Spain), L. Traversi (Cittiglio, Italy)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Late Breaking Abstract - The revival of lactate dehydrogenase (LDH) in predicting the severity of lung involvement and pneumomediastinum in hospitalized Covid-19
M. Raad (Beirut, Lebanon), H. Eid (Beirut, Lebanon), R. Ibrahim (Beirut, Lebanon), A. Kik (Beirut, Lebanon), R. Haouchan (Beirut, Lebanon), N. Nassim (Beirut, Lebanon), K. Hoyek (Beirut, Lebanon), G. Khayat (Beirut, Lebanon), F. Haddad (Beirut, Lebanon), G. Sleilaty (Beirut, Lebanon), M. Riachy (Beirut, Lebanon), m. raad (Beyrouth, Lebanon)
|   |
Late Breaking Abstract - Prone-Positioning in Awake, Non-Intubated Patients with COVID-19 Hypoxemic Failure: A Single-Center Trial
A. Duncan (Dublin, Ireland), D. Halim (Dublin, Ireland), K. Elkholy (Dublin, Ireland), S. Toland (Dublin, Ireland), I. Sulaiman (Dublin, Ireland)
| |
Late Breaking Abstract - Resolution of radiological changes on follow up chest x-ray at 6 to 12 weeks post Covid pneumonitis in a UK district general hospital
A. Anwar (Guildford, United Kingdom), E. Tubman (Guildford, United Kingdom), W. Mclean (Guildford, United Kingdom), M. Ingram (Guildford, United Kingdom), J. Scott-Taggart (Guildford, United Kingdom), C. Alexander (Guildford, United Kingdom)
| |
Late Breaking Abstract - Recovering after COVID-19: 10-month follow-up data from a multidisciplinary outpatient clinic
E. van Voorthuizen (Nijmegen, Netherlands), J. Peters (Nijmegen, Netherlands), J. Vercoulen (Nijmegen, Netherlands), M. Van Den Heuvel (Nijmegen, Netherlands), H. Van Helvoort (Nijmegen, Netherlands), J. Van Hees (Nijmegen, Netherlands), B. Van Den Borst (Nijmegen, Netherlands)
| |
Late Breaking Abstract - Fatigue, psychological and cognitive outcomes up to 12 months after hospitalization for COVID-19
L. Bek (Rotterdam, Netherlands), J. Berentschot (Rotterdam, Netherlands), S. Huijts (Rotterdam, Netherlands), H. Van Den Berg-Emons (Rotterdam, Netherlands), M. Heijenbrok-Kal (Rotterdam, Netherlands), G. Ribbers (Rotterdam, Netherlands), J. Aerts (Rotterdam, Netherlands), M. Hellemons (Rotterdam, Netherlands)
| |
Late Breaking Abstract - Physical recovery and persistent fatigue up to 12 months after hospitalization for COVID-19
J. Berentschot (Rotterdam, Netherlands), L. Bek (Rotterdam, Netherlands), S. Huijts (Rotterdam, Netherlands), H. Van Den Berg- Emons (Rotterdam, Netherlands), M. Heijenbrok-Kal (Rotterdam, Netherlands), G. Ribbers (Rotterdam, Netherlands), J. Aerts (Rotterdam, Netherlands), M. Hellemons (Rotterdam, Netherlands)
| |
Late Breaking Abstract - Tocilizumab administration for the treatment of hospitalised patients with COVID-19: A systematic review and meta-analysis
C. Kyriakopoulos (Ioannina, Greece), G. Ntritsos (Ioannina, Greece), A. Gogali (Ioannina, Greece), C. Milionis (Ioannina, Greece), E. Evangelou (Ioannina, Greece), K. Kostikas (Ioannina, Greece)
| |
Late Breaking Abstract - Management of COVID-19 pneumonia in an enhanced respiratory step down unit: a novel approach.
V. Agrawal (Warrington, United Kingdom), A. Ravi (Warrington, United Kingdom), A. Prior (Warrington, United Kingdom), J. Proctor (Warrington, United Kingdom), A. Baluwala (Warrington, United Kingdom)
| |
Late Breaking Abstract - Early follow-up of hospitalised and non-hospitalised patients with Covid-19 in a Swedish setting
M. Björnson (Solna, Sweden), D. Loewenstein (Solna, Sweden), M. Nygren Bonnier (Solna, Sweden), M. Sköld (Solna, Sweden), M. Runold (Solna, Sweden), J. Bruchfeld (Stockholm, Sweden)
| |
Late Breaking Abstract - Clinical, functional and radiological outcomes up to 12 months following COVID-19.
Y. Vande Weygaerde (Gent, Belgium), E. Claeys (Leuven, Belgium), B. Salhi (Gent, Belgium), L. Glorie (Leuven, Belgium), C. Bosteels (Gent, Belgium), W. De Wever (Leuven, Belgium), N. De Vos (Gent, Belgium), L. Godinas (Leuven, Belgium), E. Derom (Gent, Belgium), G. Hermans (Leuven, Belgium), P. Depuydt (Gent, Belgium), W. Janssens (Leuven, Belgium), E. Van Braeckel (Gent, Belgium), N. Lorent (Leuven, Belgium)
| |
RCT Abstract - Ad26.COV2.S immunogenicity in a Phase 2 trial at different booster dose levels and schedule intervals in adults
V. Cárdenas (Spring House, PA, United States of America), M. Le Gars (Leiden, Netherlands), J. Sadoff (Leiden, Netherlands), J. Ruiz Guiñazú (Beerse, Belgium), N. Vaissière (Beerse, Belgium), C. Truyers (Beerse, Belgium), G. Scheper (Leiden, Netherlands), F. Struyf (Beerse, Belgium), J. Hendriks (Leiden, Netherlands), H. Schuitemaker (Leiden, Netherlands), M. Douoguih (Leiden, Netherlands)
| |
RCT Abstract - Ad26.COV2.S induces SARS-CoV-2 spike protein-specific cellular immunity and humoral immune responses that cover variants of concern
M. Le Gars (Leiden, Netherlands), J. Sadoff (Leiden, Netherlands), G. Shukarev (Leiden, Netherlands), D. Heerwegh (Beerse, Belgium), C. Truyers (Beerse, Belgium), G. Scheper (Leiden, Netherlands), J. Hendriks (Leiden, Netherlands), M. Mcelrath (Seattle, WA, United States of America), S. De Rosa (Seattle, WA, United States of America), K. Cohen (Seattle, WA, United States of America), M. Douoguih (Leiden, Netherlands), F. Struyf (Beerse, Belgium), H. Schuitemaker (Leiden, Netherlands)
| |